SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

SCHEDULE 13G
(Rule 13d-102)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULES 13d-1(b),(c), AND (d) AND AMENDMENTS THERETO FILED
PURSUANT TO RULE 13d-2

(Amendment No.__)*

VioQuest Pharmacueticals, Inc.
(Name of Issuer)

Common Stock, $.001 par value
(Title of Class of Securities)

927625 10 3
(CUSIP Number)

December 31, 2006
(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

o Rule 13d-1(b)

o Rule 13d-1(c)

x Rule 13d-1(d)
 
*
The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
 
The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 
CUSIP No. 927625 10 3
13G
Page 2 of 5 Pages

 
1.
NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
 
Wayne William Mills
  
       
 
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
  
   
(a) o
  
   
(b) o
  
       
 
3.
SEC USE ONLY
  
       
 
4.
CITIZENSHIP OR PLACE OF ORGANIZATION
 
USA
  
 
NUMBER OF
 
SHARES
5.
SOLE VOTING POWER
 
250,000
  
       
BENEFICIALLY
 
OWNED BY
6.
SHARED VOTING POWER
 
0
  
     
EACH
 
REPORTING
7.
SOLE DISPOSITIVE POWER
 
250,000
  
       
PERSON
 
WITH
8.
SHARED DISPOSITIVE POWER
 
0
  
           
 
9.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
250,000
  
       
 
10.
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
x
  
       
 
11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
 
Less than 1%
  
       
 
12.
TYPE OF REPORTING PERSON*
 
IN
  

 
 
 
CUSIP No. 927625 10 3
13G
Page 3 of 5 Pages
 
Item 1(a).
Name of Issuer:
 
VioQuest Pharmaceuticals, Inc.
 
Item 1(b).
Address of Issuer's Principal Executive Offices:

180 Mount Airy Road, Suite 102, Basking Ridge, NJ 07920
 
Item 2(a).
Name of Person Filing:

Wayne William Mills
 
Item 2(b).
Address of Principal Business Office, or if None, Residence:

2125 Hollybush Road, Medina, MN 55340
 
Item 2(c).
Citizenship:

USA
 
Item 2(d).
Title of Class of Securities:

Common Stock, $.001 par value
 
Item 2(e).
CUSIP Number:

927625 10 3
 
Item 3.
If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a:
 
       
 
(a)
o
Broker or dealer registered under Section 15 of the Exchange Act.
       
 
(b)
o
Bank as defined in Section 3(a)(6) of the Exchange Act.
       
 
(c)
o
Insurance company as defined in Section 3(a)(19) of the Exchange Act.
       
 
(d)
o
Investment company registered under Section 8 of the Investment Company Act.
       
 
(e)
o
An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);
       
 
(f)
o
An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F);
       
 
(g)
o
A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);
       
 
(h)
o
A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act;
       
 
(i)
o
A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act;
       
 
(j)
o
Group, in accordance with Rule 13d-1(b)(1)(ii)(J).
 
 

CUSIP No. 927625 10 3
13G
Page 4 of 5 Pages

Item 4.
Ownership.

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

(a)
Amount beneficially owned:

250,000 shares (owned by Blake Capital, Inc., an affiliate of the Reporting Person)
 
(b)
Percent of class:

Less than 1% (based on 54,621,119 shares outstanding as of 12/31/06, as reported by the Issuer)
 
(c)
Number of shares as to which such person has:

(i) Sole power to vote or to direct the vote: 250,000
 
(ii) Shared power to vote or to direct the vote: 0
 
(iii) Sole power to dispose or to direct the disposition of: 250,000
 
(iv) Shared power to dispose or to direct the disposition of: 0
 
Item 5.
Ownership of Five Percent or Less of a Class.

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following        x
 
Item 6.
Ownership of More Than Five Percent on Behalf of Another Person.
 
N/A
 
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
 
N/A
 
Item 8.
Identification and Classification of Members of the Group.
 
N/A
 
Item 9.
Notice of Dissolution of Group.

N/A
 
Item 10.
Certifications.

(a)
Not applicable

(b)
Not applicable
 
 
 
SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
Dated: February 14, 2007 /s/ Wayne W. Mills
 
Wayne W. Mills
 
 
 
Exhibit A

To Form 13G (Individual)

The filing of this report shall not be construed as an admission by the person identified in Item 2(a) that, for the purpose of Section 13(d) or 13(g) of the Securities Exchange Act, he is the "beneficial owner" of any equity securities listed below; and such person expressly disclaims that he is part of a "group." The shares listed below are not included in the totals in item 9 on page 2 or 3 and are listed here for informational purposes only.

Record Owner's Relationship to Reporting Person
 
Record Owner's Type of Ownership
  
Number of Shares
         
IRA for benefit of Spouse
  
Indirect
  
2,500
         
Trust for the benefit of Reporting Person’s children*
  
Indirect
  
20,000
 
* The reporting person is not a trustee of such trust.